Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Precigen (PGEN US)
Watchlist
2
Analysis
Health Care
•
United States
Precigen, Inc. operates as a biopharmaceutical company. The Company develops gene and cell therapies to target the diseases in immuno-oncology, autoimmune disorders, and infections. Precigen serves customers worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
31 Dec 2024 05:18
Current Report (Form 8-K | Period ending 2024-12-27)
Attachment
Exchange Announcement •
27 Dec 2024 05:40
Current Report (Form 8-K | Period ending 2024-12-18)
Attachment
Exchange Announcement •
14 Nov 2024 08:00
Quarterly Report (Form 10-Q | Period ending 2024-09-30)
Attachment
Exchange Announcement •
08 Nov 2024 05:05
Current Report (Form 8-K | Period ending 2024-11-01)
Attachment
Exchange Announcement •
11 Oct 2024 04:33
Current Report (Form 8-K | Period ending 2024-10-04)
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x